Ultomiris (ravulizumab-cwvz) is a prescription drug approved to treat certain rare inflammatory conditions. Ultomiris comes as a liquid solution for intravenous (IV) infusion, which is given by a ...
The agreement is a critical step in ensuring adult patients living with NMOSD and gMG have public access to Ultomiris MISSISSAUGA, ON, Aug. 7, 2025 /CNW/ - Alexion Pharma Canada Corp., AstraZeneca's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results